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A historical study evaluated maternal outcomes in
pregnancy complicated by smallpox. The overall case fatal-
ity was estimated to be 34.3% (95% confidence interval [CI]
31.4–37.1), and the proportion of miscarriage or premature
birth was estimated to be 39.9% (95% CI 36.5–43.2).
Vaccination before pregnancy reduced the risk for death.
P
regnant women are at special risk for complications of
smallpox vaccination (1); therefore, vaccination is not
recommended for pregnant women in the absence of a
reemergence of smallpox (2). Smallpox in pregnancy is
believed to be more severe than in nonpregnant women or
adult men (3), but this consensus is based on a limited
number of studies conducted during the mid-20th century
(4–6). This article examines the outcomes of pregnancy
complicated by smallpox in historical records from the
19th and 20th centuries.
The Study
Since most large outbreaks were documented before the
mid-20th century, I collected and reviewed the literature
dating back to the 19th century. Technical details of the lit-
erature review are provided in online Appendix 1 (avail-
able at http://www.cdc.gov/ncidod/EID/vol12no07/05-
1531_app1.htm). All selected publications were retrospec-
tive studies based on epidemiologic observations of out-
breaks that reported case fatalities, miscarriages, or
premature births. Because vaccination or advances in
obstetrics over time could bias these outcomes, these fac-
tors were abstracted from each publication and considered
separately, when possible. Outcomes were then stratified
by gestation period at onset of smallpox (by trimester),
clinical classification of smallpox, and vaccination history.
Case fatalities were compared between pregnant and non-
pregnant patients. Except in Rao’s work in Madras (4),
miscarriage and premature birth were not separated, so
they are described together.
Nineteen outbreaks were identified from historical
records (4,7–20), and of these, 16 allowed estimates to be
made of case fatality, and 15 allowed estimates of the pro-
portion of miscarriage or premature birth. Of 1,074 preg-
nant patients, 368 died; and of 830 pregnant patients, 331
miscarried or gave birth prematurely (Figure). Since these
articles are from many years ago, the proportion of cases
that were undetected or unreported cannot be determined
nor can the length of time since vaccination in persons who
were vaccinated. Descriptions of excluded literature are
given in online Appendix 1; individual case records were
provided in 3 outbreaks and are included in online
Appendix 2 (available at http://www.cdc.gov/ncidod/EID/
vol12no07/05-1531_app2.htm).
Figure, panel A, shows the distribution of estimated
case fatalities for each outbreak with the corresponding
95% confidence intervals (CIs). Case fatalities varied
widely among outbreaks. The earliest outbreak in 1830
(before compulsory vaccination) yielded the highest esti-
mate (81.5%), while the 1913 outbreak in Australia had
the lowest (4.3%). The overall crude case fatality was esti-
mated to be 34.3% (95% CI 31.4–37.1). Case fatality,
stratified by gestational age at onset of smallpox, is pre-
sented in Table 1; only 4 studies enabled stratification by
gestational age. Case fatality was highest during the third
trimester, except in Queirel’s study, which included few
cases (18). Case fatality, stratified by the clinical classifi-
cation of smallpox, is shown in online Appendix 2. All
patients with hemorrhagic cases died, but all patients
without a rash (variola sine eruptione, VSE) survived.
Case fatalities among pregnant and nonpregnant
patients are compared in Appendix 2. Case fatality was not
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Figure. Maternal outcomes in pregnancies complicated by small-
pox from data from 19th- and early 20th-century outbreaks. A)
Case fatalities and B) proportions of miscarriage or premature
birth are shown. Miscarriage and premature birth before maternal
death are included.significantly higher in pregnant patients in the Rotterdam
outbreak (p = 0.33), where many VSE cases apparently
occurred. The risks for a fatal outcome among pregnant
patients in Berlin and Madras were 2.5× and 4.2× higher
than among nonpregnant patients (p<0.01 for each). I also
compared vaccinated and unvaccinated pregnant patients,
showing that the risk for death was significantly higher
among unvaccinated women in these 3 outbreaks (7/7 vs.
7/39, p<0.01; 2/2 vs. 10/78, p = 0.02; and 9/12 vs. 17/82,
p<0.01, respectively).
Crude proportions of miscarriage and premature birth,
with 95% CI, are given in the Figure, panel B. The overall
crude proportion of miscarriage or premature birth is esti-
mated to be 39.9% (95% CI 36.5–43.2). Five outbreaks
allowed stratification by gestational age at onset of small-
pox (Table 2). The overall proportion of premature birth
was highest during the last trimester of pregnancy, but no
clear pattern was seen with regard to the frequency of mis-
carriage or premature birth. The proportion of miscarriage
and premature birth, stratified by severity of smallpox, is
shown in online Appendix 2. All hemorrhagic cases result-
ed in either miscarriage or premature birth before the
mother’s death. Even mild cases, those classified as dis-
crete or VSE, tended to result in miscarriage or premature
birth. Only the 1878 outbreak in Philadelphia (10) allowed
a comparison between vaccinated and unvaccinated preg-
nant patients. Twenty-two of 39 vaccinated and 5 of 7
unvaccinated patients miscarried or delivered prematurely
(p = 0.68).
These outcomes could only be compared by history of
miscarriage in the 1913 outbreak in Australia (19). Two of
3 patients with no history and 6 of 20 with a history of mis-
carriage had a miscarriage or premature birth, but this dif-
ference was not significant (p = 0.27, odds ratio 4.7, 95%
CI 0.4–61.8). Comparison by previous experience of nor-
mal delivery (primipara or multipara) could only be per-
formed with the data from Rotterdam from 1893 and 1894
(15). Ten of 21 primipara patients and 18 of 53 multipara
patients had a miscarriage or premature birth (p = 0.30),
which suggests that delivery history did not greatly affect
the outcome of pregnancy complicated by smallpox.
Conclusions
Since outbreaks have been limited since the mid-20th
century by the successful smallpox eradication program,
historical records are a useful tool to document common
patterns of maternal outcomes in pregnancy complicated
by smallpox. Such analysis may be limited by unknown
numbers of missed or unreported cases or imperfect vacci-
nation histories. My estimates of the overall crude case
fatality and proportion of miscarriage or premature birth
were high. This study and Rao’s (4) improve our under-
standing of smallpox in pregnancy, highlighting 3 points.
First, case fatality is highest during the last trimester of
gestation, but miscarriage and premature birth do not vary
by trimester. Physiologic changes in the third trimester
could partly explain the higher case fatality (21). Second,
even mild cases were at high risk of causing miscarriage or
premature birth. Third, miscarriage and premature birth
were not significantly associated with vaccination history
or previous miscarriage or delivery. That is, vaccination
may not prevent miscarriage and premature birth.
Although prior vaccination offers less protection to
pregnant women than others (22), this study shows that
vaccination might offer at least partial protection. Case
fatality in the event of a bioterrorist attack could be
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